Skip to content

Clinical trials

Phase 2/3 Overweight trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Phase: Phase 2/3 Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20071
20082
20091
20103
20111
20132
20142
20152
20161
20191
20201
20212
20224
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting2
Unknown status2
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yale University4
Catalysis SL2
Xiaojun Chen2
Chonbuk National University Hospital1
Edgard Costa de Vilhena1
Hadassah Medical Organization1
Joslin Diabetes Center1
Lund University1
Massachusetts General Hospital1
Mayo Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight29
Obesity19
Weight Loss5
Diabetes Mellitus, Type 23
Inflammation3
Metabolic Syndrome3
Infertility2
Insulin Resistance2
Atherosclerosis1
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.